A Green WAVE Will Happen, TRUMP Will Legalize Cannabis
$Tilray Brands (TLRY.US)$
$Tilray Brands (TLRY.US)$ TLRY offers more upside reward than downside risk at current levels. TLRY is growing revenues & is trading well below it's book value of $3.97 a share, it has unfairly seen a decline in price while being fully lumped in with the cannabis sector. TLRY brings is revenues from it's bever...

$EVgo Inc (EVGO.US)$  Our Chart program alert shows a pull back below $6 within next 5 trading days is 70% likely.

$FuboTV (FUBO.US)$ We are reviewing FUBO T.V and we believe the current stock price doesn't reflect the true value. We believe a speculative investment in FUBO now offers more upside reward than downside risk.  
FUBO operates a live TV streaming platform for live sports, news, and entertainment content in the United States and internationally. The company's platform allows customers to acce...

$Tilray Brands (TLRY.US)$
$Tilray Brands (TLRY.US)$ TLRY offers more upside reward than downside risk at current levels. TLRY is growing revenues & is trading well below it's book value of $3.97 a share, it has unfairly seen a decline in price while being fully lumped in with the cannabis sector. TLRY brings is revenues from it's beverages at a growing rate. Earlier in 2024 insiders bought substantial amount of shares on the open market in the...

This $2 Stock Remains Deeply Undervalued, Profitable in 2025, Offers 10x Upside within 20 Months
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns   $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.  
This unique biotech     $Esperion Therapeutics (ESPR.US)$  Esper...

$Tilray Brands (TLRY.US)$ TLRY offers more upside reward than downside risk at current levels. TLRY is growing revenues & is trading well below it's book value of $3.97 a share, it has unfairly seen a decline in price while being fully lumped in with the cannabis sector.
TLRY is a lifestyle consumer products company that engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United St...

$FuboTV (FUBO.US)$ We are reviewing FUBO T.V and we believe the current stock price doesn't reflect the true value. We believe a speculative investment in FUBO now offers more upside reward than downside risk.  
FUBO operates a live TV streaming platform for live sports, news, and  entertainment content in the United States and internationally. The  company's platform allows customers to access content through s...

Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns   $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.  
This unique biotech   $Esperion Therapeutics (ESPR.US)$  Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary...

$Esperion Therapeutics (ESPR.US)$ An Investment Now In This Company Should Return 10 X Your Money.
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.  
This unique biotech   $Esperion Therapeutics (ESPR.US)$  Esperion has the only FDA approved statin al...

$Plug Power (PLUG.US)$ We advise traders to take profit on half your position.
Be careful with PLUG as the company is in need of cash, we see value below $2 so any profit we advise to take it